Prevention of Renal Dysfunction in Critically Ill Patients
Authors:
R. Rokyta Jr.; V. Šrámek; I. Novák; M. Matějovič; P. Hora; M. Nalos
Authors‘ workplace:
Metabolická jednotka intenzivní péče, I. interní klinika FN Plzeň, přednosta doc. MUDr. Karel Opatrný jr., CSc.
Published in:
Anest. intenziv. Med., , 2000, č. 2, s. 75-79
Category:
Overview
Acute renal failure (ARF; the most severe form of renal dysfunction) in the critically ill has a high mortality rate (50O80 %) and in most cases isa part of multiple organ dysfunction syndrome (MODS). The predominant cause of ARF in critically ill patients is acute tubular necrosis (ATN) dueto ischemia or nefrotoxic agents.The prevention of ARF is based on maintenance of adequate intravascular volume, cardiac output and renal perfusion pressure. The identificationand adequate monitoring of high-risk patients and the elimination of potential nefrotoxic agents is essential.We discuss the role of established pharmacological support (dopamine, diuretics, and calcium antagonists) as well as the place of some new agents(atrial natriuretic peptide, prostaglandins, adenosine antagonists and growth factors) in the prevention of ARF.
Key words:
acute renal failure O intensive care O prophylaxis O acute tubular necrosis O nefrotoxin
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2000 Issue 2
Most read in this issue
- Fiberoptic Intracranial Pressure Monitoring
- Noradrenalin as a pArt of the Renal Rescue Protocol
- Retrospective Study Evaluating the Effects of High Frequency Oscillatory Ventilation (HFOV) in Newborns with Respiratory Distress Syndrome
- Prevention of Renal Dysfunction in Critically Ill Patients